参考文献
［1］Sung H，Ferlay J，Siegel R L，et al.Global cancer statistics 2020：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin，2021，71（3）：209-249.
［2］Smolar J，Salemi S，Horst M，et al.Stem cells in functional bladder engineering.Transfusion medicine and hemotherapy：offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie，2016，43（5）：328-335.
［3］Anumanthan G，Makari J H，Honea L，et al.Directed differentiation of bone marrow derived mesenchymal stem cells into bladder urothelium.The Journal of Urology，2008，180（4 Suppl）：1778-1783.
［4］Zhang M，Peng Y，Zhou Z，et al.Differentiation of human adipose-derived stem cells co-cultured with urothelium cell line toward a urothelium-like phenotype in a nude murine model.Urology，2013，81（2）：465.
［5］Wu Z，Gong Z，Ao Z，et al.Rapid microfluidic formation of uniform patient-derived breast tumor spheroids.ACS Applied Bio Materials，2020，3（9）：6273-6283.
［6］Zhang Y，Mc Neill E，Tian H，et al.Urine derived cells are a potential source for urological tissue reconstruction.The Journal of Urology，2008，180（5）：2226-2233.
［7］Qin D，Long T，Deng J，et al.Urine-derived stem cells for potential use in bladder repair.Stem Cell Research＆Therapy，2014，5（3）：69.
［8］Dangles V，Lazar V，Validire P，et al.Gene expression profiles of bladder cancers：evidence for a striking effect of in vitro cell models on gene patterns.British Journal of Cancer，2002，86（8）：1283-1289.
［9］Yoshida T，Sopko N A，Kates M，et al.Three-dimensional organoid culture reveals involvement of Wnt/β-catenin pathway in proliferation of bladder cancer cells.Oncotarget，2018，9（13）：11060-11070.
［10］Booth C，Harnden P，Selby P J，et al.Towards defining roles and relationships for tenascin-C and TGFbeta-1 in the normal and neoplastic urinary bladder.The Journal of Pathology，2002，198（3）：359-368.
［11］Swietach P，Wigfield S，Cobden P，et al.Tumor-associated carbonic anhydrase 9 spatially coordinates intracellular p H in three-dimensional multicellular growths.The Journal of Biological Chemistry，2008，283（29）：20473-20483.
［12］Shin D H，Dier U，Melendez J A，et al.Regulation of MMP-1 expression in response to hypoxia is dependent on the intracellular redox status of metastatic bladder cancer cells.Biochimica et Biophysica Acta，2015，1852（12）：2593-2602.
［13］Miyake M，Hori S，Morizawa Y，et al.CXCL1-mediated interaction of cancer cells with tumorassociated macrophages and cancer-associated fibroblasts promotes tumor progression in human bladder cancer.Neoplasia（New York，N.Y.），2016，18（10）：636-646.
［14］Gottfried E，Kunz-Schughart L A，Ebner S，et al.Tumor-derived lactic acid modulates dendritic cell activation and antigen expression.Blood，2006，107（5）：2013-2021.
［15］Bentivegna A，Conconi D，Panzeri E，et al.Biological heterogeneity of putative bladder cancer stem-like cell populations from human bladder transitional cell carcinoma samples.Cancer Science，2010，101（2）：416-424.
［16］Wu K，Ning Z，Zeng J，et al.Silibinin inhibitsβ-catenin/ZEB1 Signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness.Cellular signalling，2013，25（12）：2625-2633.
［17］Becker L，Fischer F，Fleck J L，et al.Data-driven identification of biomarkers for in situ monitoring of drug treatment in bladder cancer organoids.International Journal of Molecular Sciences，2022，23（13）.
［18］Lee S H，Hu W，Matulay J T，et al.Tumor evolution and drug response in patient-derived organoid models of bladder cancer.Cell，2018，173（2）：515-528.
［19］Fullerton N E，Mairs R J，Kirk D，et al.Application of targeted radiotherapy/gene therapy to bladder cancer cell lines.European Urology，2005，47（2）：250-256.
［20］Yu L，Li Z，Mei H，et al.Patient-derived organoids of bladder cancer recapitulate antigen expression profiles and serve as a personal evaluation model for CAR-T cells in vitro.Clinical＆Translational Immunology，2021，10（2）：e1248.
［21］Colgan R，Williams M.Diagnosis and treatment of acute uncomplicated cystitis.American Family Physician，2011，84（7）：771-776.
［22］Sharma K，Thacker V V，Dhar N，et al.Early invasion of the bladder wall by solitary bacteria protects UPEC from antibiotics and neutrophil swarms in an organoid model.Cell Reports，2021，36（3）：109351.
［23］Kim E，Choi S，Kang B，et al.Creation of bladder assembloids mimicking tissue regeneration and cancer.Nature，2020，588（7839）：664-669.
［24］Åkerfelt M，Bayramoglu N，Robinson S，et al.Automated tracking of tumor-stroma morphology in microtissues identifies functional targets within the tumor microenvironment for therapeutic intervention.Oncotarget，2015，6（30）：30035-30056.
［25］Wang S，Gao D，Chen Y.The potential of organoids in urological cancer research.Nature reviews.Urology，2017，14（7）：401-414.
［26］Gong Z，Huang L，Tang X，et al.Acoustic droplet printing tumor organoids for modeling bladder tumor immune microenvironment within a week.Advanced Healthcare Materials，2021，10（22）：e2101312.
［27］Webster A C，Nagler E V，Morton R L，et al.Chronic kidney disease.Lancet，2017，389（10075）：1238-1252.
［28］Mc Mahon A P.Development of the Mammalian Kidney.Curr Top Dev Biol，2016，117：31-64.
［29］Wallace M A.Anatomy and physiology of the kidney.AORN J，1998，68（5）：800，803-816，819-820；quiz 821-804.
［30］Hamm L L，Nakhoul N，Hering-Smith K S.Acid-base homeostasis.Clin J Am Soc Nephrol，2015，10（12）：2232-2242.
［31］Sulemanji M，Vakili K.Neonatal renal physiology.Semin Pediatr Surg，2013，22（4）：195-198.
［32］Dusso A S，Brown A J，Slatopolsky E.Vitamin D.Am J Physiol Renal Physiol，2005，289（1）：F8-28.
［33］Little M H，Combes A N，Takasato M.Understanding kidney morphogenesis to guide renal tissue regeneration.Nat Rev Nephrol，2016，12（10）：624-635.
［34］Costantini F.GDNF/Ret signaling and renal branching morphogenesis：From mesenchymal signals to epithelial cell behaviors.Organogenesis，2010，6（4）：252-262.
［35］Carroll T J，Park J S，Hayashi S，et al.Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system.Dev Cell，2005，9（2）：283-292.
［36］Georgas K，Rumballe B，Valerius M T，et al.Analysis of early nephron patterning reveals a role for distal RV proliferation in fusion to the ureteric tip via a cap mesenchyme-derived connecting segment.Dev Biol，2009，332（2）：273-286.
［37］Taguchi A，Kaku Y，Ohmori T，et al.Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells.Cell Stem Cell，2014，14（1）：53-67.
［38］Takasato M，Er P X，Becroft M，et al.Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney.Nat Cell Biol，2014，16（1）：118-126.
［39］Takasato M，Er P X，Chiu H S，et al.Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis.Nature，2015，526（7574）：564-568.
［40］Morizane R，Lam A Q，Freedman B S，et al.Nephron organoids derived from human pluripotent stem cells model kidney development and injury.Nat Biotechnol，2015，33（11）：1193-1200.
［41］Homan K A，Gupta N，Kroll K T，et al.Flow-enhanced vascularization and maturation of kidney organoids in vitro.Nat Methods，2019，16（3）：255-262.
［42］Uchimura K，Wu H，Yoshimura Y，et al.Human pluripotent stem cell-derived kidney organoids with improved collecting duct maturation and injury modeling.Cell Rep，2020，33（11）：108514.
［43］Taguchi A，Nishinakamura R.Higher-order kidney organogenesis from pluripotent stem cells.Cell Stem Cell，2017，21（6）：730-746.
［44］Wu H，Uchimura K，Donnelly E L，et al.Comparative analysis and refinement of human PSCderived kidney organoid differentiation with single-cell transcriptomics.Cell Stem Cell，2018，23（6）：869-881.
［45］Schutgens F，Rookmaaker M B，Margaritis T，et al.Tubuloids derived from human adult kidney and urine for personalized disease modeling.Nat Biotechnol，2019，37（3）：303-313.
［46］Morizane R，Bonventre J V.Kidney organoids：A translational journey.Trends Mol Med，2017，23（3）：246-263.
［47］Vanslambrouck J M，Wilson S B，Tan K S，et al.A toolbox to characterize human induced pluripotent stem cell-derived kidney cell types and organoids.J Am Soc Nephrol，2019，30（10）：1811-1823.
［48］Yoshimura Y，Taguchi A，Tanigawa S，et al.Manipulation of nephron-patterning signals enables selective induction of podocytes from human pluripotent stem cells.J Am Soc Nephrol，2019，30（2）：304-321.
［49］Freedman B S，Brooks C R，Lam A Q，et al.Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids.Nat Commun，2015，6：8715.
［50］Cruz N M，Song X，Czerniecki S M，et al.Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease.Nat Mater，2017，16（11）：1112-1119.
［51］Low J H，Li P，Chew E G Y，et al.Generation of human PSC-derived kidney organoids with patterned nephron segments and a de novo vascular network.Cell Stem Cell，2019，25（3）：373-387.(https://www.daowen.com)
［52］Howden S E，Wilson S B，Groenewegen E，et al.Plasticity of distal nephron epithelia from human kidney organoids enables the induction of ureteric tip and stalk.Cell Stem Cell，2021，28（4）：671-684.
［53］Shimizu T，Mae S I，Araoka T，et al.A novel ADPKD model using kidney organoids derived from disease-specific human iPSCs.Biochem Biophys Res Commun，2020，529（4）：1186-1194.
［54］Shamshirgaran Y，Jonebring A，Svensson A，et al.Rapid target validation in a Cas9-inducible hiPSC derived kidney model.Sci Rep，2021，11（1）：16532.
［55］Tanigawa S，Islam M，Sharmin S，et al.Organoids from nephrotic disease-derived iPSCs identify impaired NEPHRIN localization and slit diaphragm formation in kidney podocytes.Stem Cell Reports，2018，11（3）：727-740.
［56］Ohmori T，De S，Tanigawa S，et al.Impaired NEPHRIN localization in kidney organoids derived from nephrotic patient iPS cells.Sci Rep，2021，11（1）：3982.
［57］Hale L J，Howden S E，Phipson B，et al.3D organoid-derived human glomeruli for personalised podocyte disease modelling and drug screening.Nat Commun，2018，9（1）：5167.
［58］Jansen J，van den Berge B T，van den Broek M，et al.Human pluripotent stem cell-derived kidney organoids for personalized congenital and idiopathic nephrotic syndrome modeling.Development，2022，149（9）：dev200198.
［59］Romagnani P，Remuzzi G，Glassock R，et al.Chronic kidney disease.Nat Rev Dis Primers，2017，3：17088.
［60］Mulder J，Sharmin S，Chow T，et al.Generation of infant-and pediatric-derived urinary induced pluripotent stem cells competent to form kidney organoids.Pediatr Res，2020，87（4）：647-655.
［61］Mae S I，Ryosaka M，Sakamoto S，et al.Expansion of human iPSC-derived ureteric bud organoids with repeated branching potential.Cell Rep，2020，32（4）：107963.
［62］Forbes T A，Howden S E，Lawlor K，et al.Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype and reveal underlying pathogenetic mechanisms.Am J Hum Genet，2018，102（5）：816-831.
［63］Liu E，Radmanesh B，Chung B H，et al.Profiling APOL1 nephropathy risk variants in genomeedited kidney organoids with single-cell transcriptomics.Kidney360，2020，1（3）：203-215.
［64］Kim J W，Kim H W，Nam S A，et al.Human kidney organoids reveal the role of glutathione in Fabry disease.Exp Mol Med，2021，53（10）：1580-1591.
［65］Helms L，Marchiano S，Stanaway I B，et al.Cross-validation of SARS-Co V-2 responses in kidney organoids and clinical populations.JCI Insight，2021，6（24）.
［66］Jansen J，Reimer K C，Nagai J S，et al.SARS-Co V-2 infects the human kidney and drives fibrosis in kidney organoids.Cell Stem Cell，2022，29（2）：217-231.
［67］Calandrini C，Schutgens F，Oka R，et al.An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity.Nat Commun，2020，11（1）：1310.
［68］Wegert J，Zauter L，Appenzeller S，et al.High-risk blastemal wilms tumor can be modeled by 3D spheroid cultures in vitro.Oncogene，2020，39（4）：849-861.
［69］Li Z，Xu H，Yu L，et al.Patient-derived renal cell carcinoma organoids for personalized cancer therapy.Clin Transl Med，2022，12（7）：e970.
［70］Dvela-Levitt M，Kost-Alimova M，Emani M，et al.Small molecule targets TMED9 and promotes lysosomal degradation to reverse proteinopathy.Cell，2019，178（3）：521-535.
［71］Czerniecki S M，Cruz N M，Harder J L，et al.High-throughput screening enhances kidney organoid differentiation from human pluripotent stem cells and enables automated multidimensional phenotyping.Cell Stem Cell，2018，22（6）：929-940.
［72］Monteil V，Kwon H，Prado P，et al.Inhibition of SARS-Co V-2 infections in engineered human tissues using clinical-grade soluble human ACE2.Cell，2020，181（4）：905-913.
［73］Wysocki J，Ye M，Hassler L，et al.A novel soluble ACE2 variant with prolonged duration of action neutralizes SARS-Co V-2 infection in human kidney organoids.J Am Soc Nephrol，2021，32（4）：795-803.
［74］Digby J L M，Vanichapol T，Przepiorski A，et al.Evaluation of cisplatin-induced injury in human kidney organoids.Am J Physiol Renal Physiol，2020，318（4）：F971-F978.
［75］Kim J W，Nam S A，Seo E，et al.Human kidney organoids model the tacrolimus nephrotoxicity and elucidate the role of autophagy.Korean J Intern Med，2021，36（6）：1420-1436.
［76］Gulieva R E，Higgins A Z.Human induced pluripotent stem cell derived kidney organoids as a model system for studying cryopreservation.Cryobiology，2021，103：153-156.
［77］Lawrence M L，Elhendawi M，Morlock M，et al.Human iPSC-derived renal organoids engineered to report oxidative stress can predict drug-induced toxicity.iScience，2022，25（3）：103884.
［78］Shankar A S，Du Z，Mora H T，et al.Human kidney organoids produce functional renin.Kidney Int，2021，99（1）：134-147.
［79］Shankar A S，van den Berg S A A，Tejeda Mora H，et al.Vitamin D metabolism in human kidney organoids.Nephrol Dial Transplant，2021，37（1）：190-193.
［80］Gupta N，Matsumoto T，Hiratsuka K，et al.Modeling injury and repair in kidney organoids reveals that homologous recombination governs tubular intrinsic repair.Sci Transl Med，2022，14（634）：eabj4772.
［81］Ungricht R，Guibbal L，Lasbennes M C，et al.Genome-wide screening in human kidney organoids identifies developmental and disease-related aspects of nephrogenesis.Cell Stem Cell，2022，29（1）：160-175.
［82］Verze P，Cai T，Lorenzetti S.The role of the prostate in male fertility，health and disease.Nat Rev Urol，2016，13（7）：379-386.
［83］Wang G，Zhao D，Spring D J，et al.Genetics and biology of prostate cancer.Genes Dev，2018，32（17-18）：1105-1140.
［84］Guo W，Li L，He J，et al.Single-cell transcriptomics identifies a distinct luminal progenitor cell type in distal prostate invagination tips.Nat Genet，2020，52（9）：908-918.
［85］Chua C W，Shibata M，Lei M，et al.Single luminal epithelial progenitors can generate prostate organoids in culture.Nat Cell Biol，2014，16（10）：951-961，951-954.
［86］Crowley L，Cambuli F，Aparicio L，et al.A single-cell atlas of the mouse and human prostate reveals heterogeneity and conservation of epithelial progenitors.Elife，2020，9.
［87］Rane J K，Droop A P，Maitland N J.A detailed analysis of gene expression in human basal，luminal，and stromal cell populations from benign prostatic hyperplasia tissues and comparisons with cultured basal cells.Eur Urol，2017，72（1）：157-159.
［88］Davies A H，Beltran H，Zoubeidi A.Cellular plasticity and the neuroendocrine phenotype in prostate cancer.Nat Rev Urol，2018，15（5）：271-286.
［89］Beltran H，Rickman D S，Park K，et al.Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets.Cancer Discov，2011，1（6）：487-495.
［90］Beltran H，Oromendia C，Danila D C，et al.A phase II trial of the aurora kinase A inhibitor alisertib for patients with castration-resistant and neuroendocrine prostate cancer：Efficacy and biomarkers.Clin Cancer Res，2019，25（1）：43-51.
［91］Drost J，Karthaus W R，Gao D，et al.Organoid culture systems for prostate epithelial and cancer tissue.Nat Protoc，2016，11（2）：347-358.
［92］Chun-Wai M，Yu S，Soon-Keng C，et al.Prostate organoid technology—the new POT of gold in prostate stem cell and cancer research.Acta Physiologica Sinica，2021.
［93］Puca L，Bareja R，Prandi D，et al.Patient derived organoids to model rare prostate cancer phenotypes.Nat Commun，2018，9（1）：2404.
［94］Gao D，Vela I，Sboner A，et al.Organoid cultures derived from patients with advanced prostate cancer.Cell，2014，159（1）：176-187.
［95］Nguyen H M，Vessella R L，Morrissey C，et al.LuCaP prostate cancer patient-derived xenografts reflect the molecular heterogeneity of advanced disease and serve as models for evaluating cancer therapeutics.Prostate，2017，77（6）：654-671.
［96］Pietrzak K，Kuzyakiv R，Simon R，et al.TIP5 primes prostate luminal cells for the oncogenic transformation mediated by PTEN-loss.Proc Natl Acad Sci U S A，2020，117（7）：3637-3647.
［97］Talos F，Mitrofanova A，Bergren S K，et al.A computational systems approach identifies synergistic specification genes that facilitate lineage conversion to prostate tissue.Nat Commun，2017，8：14662.
［98］Carver B S，Chapinski C，Wongvipat J，et al.Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer.Cancer Cell，2011，19（5）：575-586.
［99］Dai X，Gan W，Li X，et al.Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4.Nat Med，2017，23（9）：1063-1071.
［100］Viswanathan V S，Ryan M J，Dhruv H D，et al.Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway.Nature，2017，547（7664）：453-457.
［101］Sachs N，de Ligt J，Kopper O，et al.A living biobank of breast cancer organoids captures disease heterogeneity.Cell，2018，172（1-2）：373-386.
［102］Lin D，Wyatt A W，Xue H，et al.High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development.Cancer Res，2014，74（4）：1272-1283.